# FDA recall D-0161-2023

> **Lannett Company Inc.** · Class III · drug recall initiated 2022-11-09.

## Product

Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, [100 or 1000 ] Capsules per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136.  NDC 100 Count bottle: 0527-1632-01; NDC 1,000 bottle: 0527-1632-10

## Reason for recall

Failed Impurity/Degradation Specifications

## Distribution

Nationwide USA

## Key facts

- **Recall number:** D-0161-2023
- **Recalling firm:** Lannett Company Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-11-09
- **Report date:** 2023-01-25
- **Termination date:** 2023-06-08

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Seymour, IN, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0161-2023

## Citation

> AI Analytics. FDA recall D-0161-2023. Retrieved 2026-06-03 from https://api.ai-analytics.org/recall/D-0161-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*